HyClone™ Defined Fetal Bovine Serum (FBS), New Zealand Origin, 100 mL, Heat Inactivated
Welldefined: assay results for over 50 components, with additional testing available
NZ origin: sourced and processed in New Zealand with complete traceability to origin
Ultralow endotoxin: = 5 EU/mL endotoxin for reduced research and production risk
Sterilefiltered: proprietary serial 40 nm filter process
Postfiltration treatments: ?irradiated and heatinactivated FBS options are available
Virustested: broad virus panel testing in accordance with 9 CFR 113.53
Our highest quality FBS, HyClone™ AUorigin defined FBS is proprietary serial 40 nmfiltered, virustested to 9 CFR standard, and supplied with an extensive biochemical profile.
Fetal bovine serum (FBS) is a nutrientrich cell culture supplement that is high in growth factors and low in antibodies, compared to nonfetal sera.
Defined FBS for cell culture confidence and consistency
HyClone™ Defined FBS is widely used by cell culturists who have a concern for viral contaminants and require an extensive biochemical profile. The final serum is assayed for over 50 components, including proteins, hormones, growth factors, metabolites, and nutrients important for cell culture. Assay results are included in the certificate of analysis and the biochemical assay list. Additional testing, including EMEA conformance testing, is also available.
Exceptionally low endotoxin levels
Endotoxin contamination is a significant concern when producing cell culturederived products for use in humans or animals. The presence of endotoxin in cell cultures can also have adverse and unpredictable effects on cell growth, function and phenotype that can compromise research results. Our patented closedsystem blood collection method and rigorous quality control testing ensure that HyClone™ Defined FBS contains = 5 EU/mL endotoxin and = 15 mg/dL hemoglobin. Low hemoglobin levels in the final product are an indication that extensive cell lysis has not occurred, confirming that the fetal blood has been handled appropriately during collection and transport.
Postfiltration treatments for added process security
Gammairradiated and heatinactivated FBS options are available to further reduce the risk of adventitious agents, particularly when manufacturing products for use in humans or animals. The irradiation process is validated to deliver multiple validated dose ranges starting at 25 kGy.